{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447931828
| IUPAC_name = 7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-3''H''-1,4-benzodiazepin-2-one
| image = Flutoprazepam.svg
| width = 175
| image2 = Flutoprazepam ball-and-stick.png
| width2 = 180

<!--Clinical data-->
| tradename = Restas
| Drugs.com = {{drugs.com|international|flutoprazepam}}
| pregnancy_US = X
| legal_CA = Schedule IV
| legal_US = Unscheduled
| legal_status = 
| routes_of_administration = Oral, Intravenous

<!--Pharmacokinetic data-->
| bioavailability = 80-90%
| metabolism = Hepatic
| elimination_half-life = 60-90 hours
| excretion = Renal

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 25967-29-7
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2106743	
| ATC_prefix = none
| PubChem = 3400
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3283
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2GHY1101MM
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01279

<!--Chemical data-->
| C=19 | H=16 | Cl=1 | F=1 | N=2 | O=1 
| molecular_weight = 342.795
| smiles = FC1=CC=CC=C1C2=NCC(N(CC3CC3)C4=C2C=C(C=C4)Cl)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H16ClFN2O/c20-13-7-8-17-15(9-13)19(14-3-1-2-4-16(14)21)22-10-18(24)23(17)11-12-5-6-12/h1-4,7-9,12H,5-6,10-11H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OFVXPDXXVSGEPX-UHFFFAOYSA-N
}}

'''Flutoprazepam''' ('''Restas''') is a drug which is a [[benzodiazepine]]. It was patented in Japan by Sumitomo in 1972<ref>{{ cite patent
 | country = US
 | number = 3632574
 | status = patent
 | title = PROCESS FOR PRODUCING BENZODIAZEPINE DERIVATIVES
 | pubdate = 1968-29-04
 | gdate = 1972-04-01
 | inventor = Hisao Yamamoto et al
}}</ref> and its medical use remains mostly confined to that country. Its [[muscle relaxant]] properties are approximately equivalent to those of [[diazepam]] - however, it has more powerful [[sedative]], [[hypnotic]], [[anxiolytic]] and [[anticonvulsant]] effects and is around four times more potent by weight compared to diazepam.<ref>{{Cite journal | doi = 10.1254/fpj.76.447 | last1 = Sukamoto | first1 = T. | last2 = Aikawa | first2 = K. | last3 = Itoh | first3 = K. | last4 = Nose | first4 = T. | title = [Psycopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)] | journal = Nippon Yakurigaku Zasshi | volume = 76 | issue = 6 | pages = 447–68 |date=Sep 1980 | pmid = 7203280 }}</ref> It is longer acting than diazepam due to its long-acting active metabolites,<ref>{{Cite journal | doi = 10.1254/fpj.80.15 | last1 = Ueki | first1 = S. | last2 = Sukamoto | first2 = T. | last3 = Watanabe | first3 = S. | last4 = Yamamoto | first4 = T. | last5 = Kataoka | first5 = Y. | last6 = Shibata | first6 = S. | last7 = Suwandi | first7 = D. | last8 = Shibata | first8 = K. | last9 = Takano | first9 = M. | last10 = Sukamoto | first10 = Takayuki | title = [Behavioral effects of flutoprazepam (KB-509) and its metabolites] | journal = Nippon Yakurigaku Zasshi | volume = 80 | issue = 1 | pages = 15–30 |date=Jul 1982 | pmid = 6890927 | display-authors = 8 }}</ref> which contribute significantly to its effects.<ref>{{Cite journal | doi = 10.1007/BF03190114 | last1 = Barzaghi | first1 = N. | last2 = Leone | first2 = L. | last3 = Monteleone | first3 = M. | last4 = Tomasini | first4 = G. | last5 = Perucca | first5 = E. | title = Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects. | journal = Eur J Drug Metab Pharmacokinet | volume = 14 | issue = 4 | pages = 293–8 | pmid = 2633923 | year = 1989 }}</ref>

Flutoprazepam is typically used for the treatment of severe [[insomnia]] and may also be used for treating [[stomach ulcer]]s.<ref>{{Cite journal | doi = 10.1254/fpj.77.273 | last1 = Fukuda | first1 = T. | last2 = Itoh | first2 = K. | last3 = Nose | first3 = T. | title = [Antiulcerogenic action of 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (KB-509), a new benzodiazepine derivative] | journal = Nippon Yakurigaku Zasshi | volume = 77 | issue = 3 | pages = 273–80 |date=Mar 1981 | pmid = 7052359 }}</ref>

Flutoprazepam does not fall under the international [[Convention on Psychotropic Substances]] of 1971, and is currently unscheduled in the United States.<ref>{{cite web|title=Green List—List of psychotropic substances under international control |url=https://www.incb.org/documents/Psychotropics/greenlist/2016/V1604744_Eng.pdf |format=PDF |date= August 2016 |edition=26th |publisher=International Narcotics Control Board}}</ref>

*In [[Singapore]], flutoprazepam is a [[Misuse of Drugs Act (Singapore)#Class C - Part III|Class C-Schedule II]] drug under the [[Misuse of Drugs Act (Singapore)|Misuse of Drugs Act]].
*In [[Thailand]], flutoprazepam is a [[Psychotropic Substances Act (Thailand)#Schedule III|Schedule III]] psychotropic substance.
*In [[Hong Kong]], flutoprazepam is regulated under Schedule 1 of [[Hong Kong|Hong Kong's]] Chapter 134 ''Dangerous Drugs Ordinance''. Flutoprazepam can only be used legally by health professionals and for university research purposes. The substance can be given by pharmacists under a prescription. Anyone who supplies the substance without prescription can be fined $10000 (HKD). The penalty for trafficking or manufacturing the substance is a $5,000,000 ([[Hong Kong dollar|HKD]]) fine and life imprisonment. Possession of the substance for consumption without license from the Department of Health is illegal with a $1,000,000 (HKD) fine and/or 7 years of jail time.<ref>{{cite web |title=Bilingual Laws Information System |url=http://www.legislation.gov.hk/eng/index.htm |format=English |publisher=The Government of the Hong Kong Special Administrative Region of the People's Republic of China}}</ref>

==See also==
*[[Benzodiazepine]]

==References==
<references/>

{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Lactams]]
[[Category:Fluoroarenes]]